chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: FLU4, PNC20
Symptoms: Troponin increased, Vomiting
Clinical narrative: Reported Symptoms: 10002218:ANAPHYLAXIS; 10002391:ANGINAL PAIN; 10011232:COUGHING; 10019211:HEADACHE; 10040604:SHORTNESS OF BREATH; 1004700:VOMITING; Narrative: 44 YO M w/ PMHx of nephrolithiasis, alcohol use disorder, chronic neuropathic pain, PTSD, and depression presented to primary care clinic for a routine follow-up and received influenza (Fluzone) and 20-valent pneumococcal conjugate (Prevnar 20) vaccines at approximately 9:15 AM on 9/19/23. Patient called the nurse triage line at approximately 9:00 PM to report a burning sensation in his chest, headache, and cough that had started gradually after receiving the immunizations and was directed to go to the emergency room. He presented to the emergency room reporting the previous symptoms as well as shortness of breath. Symptoms progressed to also include hoarse voice, nausea, vomiting, and feeling of "tickling in throat" similar to anaphylactic reactions to shellfish in the past. Of note, patient has received the influenza vaccine previously without adverse reactions noted. He received 4 puffs of inhaled albuterol, epinephrine 0.3mg IM, methylprednisolone 125mg IV, diphenhydramine 50mg IV, ondansetron 4mg IV, famotidine 20mg IV, and 1 L of Lactated Ringer's with improvement in symptoms. He received an additional epinephrine 0.3mg IM and acetaminophen 650mg by mouth for remaining tightness in throat/chest and headache. Following further improvement and stability, patient was discharged from the emergency room with Epi-Pens, famotidine 20mg BID as needed for allergic reaction, and methylprednisolone dose pack. On 9/21/23, he reported to primary care nurse that symptoms were continuing to improve though still noted some remaining shortness of breath on exertion. Other Relevant HX: Patient has previously received flu shot (2022, 2021, 2019, 2015, 2010) without adverse reactions. Other: shortness of breath
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Reported Symptoms:  10011232: COUGHING; 10040742:SINUS CONGESTION; Narrative:  Other Relevant HX:  Pt was admitted for reasons other than COVID-19 Tested positive while inpatient and was symptomatic with sinus congestion and cough.  Treated with remdesivir 11/2/22-11/23/22.  Other:  cough, sinus congestion
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain, Angiogram abnormal, Asthenia, Bacteraemia, Brain fog
Clinical narrative: Reported Symptoms: 10000081:ABDOMINAL PAIN; 10013573:DIZZINESS; 10016558:FEVER; 10047862:WEAKNESS; 10052104:DRY HEAVES; Narrative: Patient admitted for COVID-19 pneumonia, bacteremia. Required treatment with Remdesivir, dexamethasone, zinc, vitamin C and ceftriaxone, metronidazole for pneumonia and bacteremia. Was discharged after 11 day hospital stay in improved condition. Other Relevant HX: Patient is a 75-year-old male with a past medical history that includes hypertension, COPD, hepatitis C, gastrointestinal stromal tumor status post imatinib and partial gastrectomy, pneumonia. Presented to emergency department with complaints of 1 week of dizziness, cough, fatigue, "brain fog." Tested positive for COVID-19 in the ED and was noted to have hypoxemia during ambulation. CTA abdomen also showed findings concerning for left lower lobe pneumonia. Pt admitted for patient admitted for COVID-19 and hypoxemia. Pt was treated with Remdesivir and dexamethasone, zinc, vitamin C. Also received ceftriaxone and metronidazole for community acquired bacterial pneumonia/Streptococcus constellatus bacteremia. Other: weakness, abd pan, dryheaves
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, COVID-19 pneumonia, Computerised tomogram abdomen, Cough, Dizziness
Clinical narrative: Reported Symptoms: 10000081:ABDOMINAL PAIN; 10013573:DIZZINESS; 10016558:FEVER; 10047862:WEAKNESS; 10052104:DRY HEAVES; Narrative: Patient admitted for COVID-19 pneumonia, bacteremia. Required treatment with Remdesivir, dexamethasone, zinc, vitamin C and ceftriaxone, metronidazole for pneumonia and bacteremia. Was discharged after 11 day hospital stay in improved condition. Other Relevant HX: Patient is a 75-year-old male with a past medical history that includes hypertension, COPD, hepatitis C, gastrointestinal stromal tumor status post imatinib and partial gastrectomy, pneumonia. Presented to emergency department with complaints of 1 week of dizziness, cough, fatigue, "brain fog." Tested positive for COVID-19 in the ED and was noted to have hypoxemia during ambulation. CTA abdomen also showed findings concerning for left lower lobe pneumonia. Pt admitted for patient admitted for COVID-19 and hypoxemia. Pt was treated with Remdesivir and dexamethasone, zinc, vitamin C. Also received ceftriaxone and metronidazole for community acquired bacterial pneumonia/Streptococcus constellatus bacteremia. Other: weakness, abd pan, dryheaves
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fatigue, Hypoxia, Pneumonia, Pyrexia, Retching
Clinical narrative: Reported Symptoms: 10000081:ABDOMINAL PAIN; 10013573:DIZZINESS; 10016558:FEVER; 10047862:WEAKNESS; 10052104:DRY HEAVES; Narrative: Patient admitted for COVID-19 pneumonia, bacteremia. Required treatment with Remdesivir, dexamethasone, zinc, vitamin C and ceftriaxone, metronidazole for pneumonia and bacteremia. Was discharged after 11 day hospital stay in improved condition. Other Relevant HX: Patient is a 75-year-old male with a past medical history that includes hypertension, COPD, hepatitis C, gastrointestinal stromal tumor status post imatinib and partial gastrectomy, pneumonia. Presented to emergency department with complaints of 1 week of dizziness, cough, fatigue, "brain fog." Tested positive for COVID-19 in the ED and was noted to have hypoxemia during ambulation. CTA abdomen also showed findings concerning for left lower lobe pneumonia. Pt admitted for patient admitted for COVID-19 and hypoxemia. Pt was treated with Remdesivir and dexamethasone, zinc, vitamin C. Also received ceftriaxone and metronidazole for community acquired bacterial pneumonia/Streptococcus constellatus bacteremia. Other: weakness, abd pan, dryheaves
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Streptococcal bacteraemia
Clinical narrative: Reported Symptoms: 10000081:ABDOMINAL PAIN; 10013573:DIZZINESS; 10016558:FEVER; 10047862:WEAKNESS; 10052104:DRY HEAVES; Narrative: Patient admitted for COVID-19 pneumonia, bacteremia. Required treatment with Remdesivir, dexamethasone, zinc, vitamin C and ceftriaxone, metronidazole for pneumonia and bacteremia. Was discharged after 11 day hospital stay in improved condition. Other Relevant HX: Patient is a 75-year-old male with a past medical history that includes hypertension, COPD, hepatitis C, gastrointestinal stromal tumor status post imatinib and partial gastrectomy, pneumonia. Presented to emergency department with complaints of 1 week of dizziness, cough, fatigue, "brain fog." Tested positive for COVID-19 in the ED and was noted to have hypoxemia during ambulation. CTA abdomen also showed findings concerning for left lower lobe pneumonia. Pt admitted for patient admitted for COVID-19 and hypoxemia. Pt was treated with Remdesivir and dexamethasone, zinc, vitamin C. Also received ceftriaxone and metronidazole for community acquired bacterial pneumonia/Streptococcus constellatus bacteremia. Other: weakness, abd pan, dryheaves
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bronchitis, COVID-19, Chills, Hypokalaemia, Pyrexia
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10016558:FEVER;  10021018:HYPOKALEMIA;  10040047:SEPSIS;  10084401:COVID-19 RESPIRATORY INFECTION;   Narrative:  Patient received five doses of Pfizer COVID 19 Vaccine (Feb/Mar/Dec 2021) and (May/Dec 2021).  The patient presented to the ED on 25 Aug 23 with fever, chills, and foul-smelling urine.  The patient tested positive for COVID-19 on 25 August 23.   The patient was admitted to the hospital on 25 Aug 23 with sepsis,  covid 19, hypokalemia,  and UTI.   The patient was treated with antibiotics and electrolytes and discharged on 28 August 2023 in stable condition.  Patient did develop post covid bronchitis and was seen in the ED on 6 Sep 23.   Reported per EUA.   Other Relevant HX:   Other: sepsis, covid 19, hypokalemia
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Urinary tract infection, Urine odour abnormal
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10016558:FEVER;  10021018:HYPOKALEMIA;  10040047:SEPSIS;  10084401:COVID-19 RESPIRATORY INFECTION;   Narrative:  Patient received five doses of Pfizer COVID 19 Vaccine (Feb/Mar/Dec 2021) and (May/Dec 2021).  The patient presented to the ED on 25 Aug 23 with fever, chills, and foul-smelling urine.  The patient tested positive for COVID-19 on 25 August 23.   The patient was admitted to the hospital on 25 Aug 23 with sepsis,  covid 19, hypokalemia,  and UTI.   The patient was treated with antibiotics and electrolytes and discharged on 28 August 2023 in stable condition.  Patient did develop post covid bronchitis and was seen in the ED on 6 Sep 23.   Reported per EUA.   Other Relevant HX:   Other: sepsis, covid 19, hypokalemia
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Palpitations
Clinical narrative: Reported Symptoms:  10033556:PALPITATION;   Narrative: Pt reported history of palpations he attributed to the covid vaccine he had received in the past. He refused any future booster covid vaccinations. His PCP Md flagged pt's chart with ADR to covid vaccine. PT DID NOT RECEIVE ANY COVID VACCINE FROM facility. No specific info is available from facility regarding the vaccines this patient received or place where he received them from. Other Relevant Hx: Other: PALPITATIONS
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, Cough, Diarrhoea, Malaise
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10012727:DIARRHEA;  10038436:RENAL FAILURE ACUTE;  10040047:SEPSIS;  10047700:VOMITING;  10084401:COVID-19 RESPIRATORY INFECTION;   Narrative:  The patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the ED on 19 Aug 2023 with cough, nausea, diarrhea, and general malaise.   The patient tested positive for COVID 19 on 19 August 2023.   The patient was admitted to the hospital on 19 Aug 23 with sepsis, acute kidney injury, and COVID.   The patient was treated with antibiotics and electrolytes and discharged on 22 August 2023 in stable condition.   Reported per EUA.   Other Relevant HX:   Other:  COVID 19,  sepsis
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test positive, Sepsis, Vomiting
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10012727:DIARRHEA;  10038436:RENAL FAILURE ACUTE;  10040047:SEPSIS;  10047700:VOMITING;  10084401:COVID-19 RESPIRATORY INFECTION;   Narrative:  The patient received three doses of Moderna COVID 19 Vaccine (Feb/Mar/Dec 2021). The patient presented to the ED on 19 Aug 2023 with cough, nausea, diarrhea, and general malaise.   The patient tested positive for COVID 19 on 19 August 2023.   The patient was admitted to the hospital on 19 Aug 23 with sepsis, acute kidney injury, and COVID.   The patient was treated with antibiotics and electrolytes and discharged on 22 August 2023 in stable condition.   Reported per EUA.   Other Relevant HX:   Other:  COVID 19,  sepsis
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Back pain, Dyspnoea, Pain
Clinical narrative: Reported Symptoms: Narrative: Patient telephoned the clinic and reported that her shoulder became sore and began to radiate into her back. She states that two days after the vaccine (Sunday 10/22/2023) her back was so sore that breathing was difficult. However at the time of the telephone conversation the severity has subsided. Other Relevant HX: Other:
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulation drug level above therapeutic, COVID-19, Clostridium difficile infection, Cough, Diarrhoea
Clinical narrative: Reported Symptoms:  10012727:DIARRHEA;  10038678:RESPIRATORY DEPRESSION;  10084268:COVID-19;     Narrative:  Patient received 4 doses Pfizer COVID 19 vaccine (Jan/Feb/Sep21 and Apr 22) and 1 dose Moderna COVID 19 vaccine in May 2023.  The patient presented to the ED on 15 August 2023 on 15 Aug 23 with diarrhea, cough, fatigue, and severe shortness of breath.  The patient tested positive for COVID 19 on 12 August 2023.  The patient was admitted with respiratory failure, supratherapeutic INR, and C.diff on 15 August 2023 after 4 days of molnupiravir.  The patient was treated with antibiotics and supportive care and discharge in stable condition on 18 August 2023.  Reported per EUA.    Other Relevant HX:   Other:  Covid 19
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Respiratory depression, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10012727:DIARRHEA;  10038678:RESPIRATORY DEPRESSION;  10084268:COVID-19;     Narrative:  Patient received 4 doses Pfizer COVID 19 vaccine (Jan/Feb/Sep21 and Apr 22) and 1 dose Moderna COVID 19 vaccine in May 2023.  The patient presented to the ED on 15 August 2023 on 15 Aug 23 with diarrhea, cough, fatigue, and severe shortness of breath.  The patient tested positive for COVID 19 on 12 August 2023.  The patient was admitted with respiratory failure, supratherapeutic INR, and C.diff on 15 August 2023 after 4 days of molnupiravir.  The patient was treated with antibiotics and supportive care and discharge in stable condition on 18 August 2023.  Reported per EUA.    Other Relevant HX:   Other:  Covid 19
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-19 RESPIRATORY INFECTION;  Narrative:  Other Relevant HX: Other:  COVID Breakthrough
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Diarrhoea, Dyspnoea, Fatigue
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10011906:DEATH; 10016550:FEVER; 10028411:MYALGIA; 10047700:VOMITING; Narrative:  SUBJECTIVE: pt seen and examined.chart reviewed overnight events noted  no dyspnea hb 7.7 long discussion with Pharmacist will check PTT as pt bolused twice on heparin and Factor X a is not at goal.  pt currently on 31/min oxygen    if his hb trends down then we may need to stop all anticoagulation given risk of bleeding and patient is then agreeable to consider hospice on discharge  Comments:  THIS WRITER RECEIVED CPRS ALERT FROM FACILITY STAFF REGARDING PATIENT PASSING; VERIFIED INFORMATION.  FACILITY STAFF STATES PATIENT DOD 04/13/2023 TOD 0926 with HOME HEALTH AGENCY.  PATIENT, ON BEHALF OF THE FACILITY, REST IN PEACE.  Other Relevant HX:  Patient is a 79 y.o m, with history that includes, stage II ("Bulky") Mantle cell Lymphoma made by a celiac lymph node biopsy on 10/12/17. Last  chemotherapy of Rituximab on 12/12/22, here at facility.  The patient presented testerday to facility ED with 2 days history of fever   (Tmax 103), fatigue, vomiting,diarrhea,  decerase oral intake, generalized  body aches, dyspnea and dry cough.  Other:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypophagia, Myalgia, Pain, Pyrexia
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10011906:DEATH; 10016550:FEVER; 10028411:MYALGIA; 10047700:VOMITING; Narrative:  SUBJECTIVE: pt seen and examined.chart reviewed overnight events noted  no dyspnea hb 7.7 long discussion with Pharmacist will check PTT as pt bolused twice on heparin and Factor X a is not at goal.  pt currently on 31/min oxygen    if his hb trends down then we may need to stop all anticoagulation given risk of bleeding and patient is then agreeable to consider hospice on discharge  Comments:  THIS WRITER RECEIVED CPRS ALERT FROM FACILITY STAFF REGARDING PATIENT PASSING; VERIFIED INFORMATION.  FACILITY STAFF STATES PATIENT DOD 04/13/2023 TOD 0926 with HOME HEALTH AGENCY.  PATIENT, ON BEHALF OF THE FACILITY, REST IN PEACE.  Other Relevant HX:  Patient is a 79 y.o m, with history that includes, stage II ("Bulky") Mantle cell Lymphoma made by a celiac lymph node biopsy on 10/12/17. Last  chemotherapy of Rituximab on 12/12/22, here at facility.  The patient presented testerday to facility ED with 2 days history of fever   (Tmax 103), fatigue, vomiting,diarrhea,  decerase oral intake, generalized  body aches, dyspnea and dry cough.  Other:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10011906:DEATH; 10016550:FEVER; 10028411:MYALGIA; 10047700:VOMITING; Narrative:  SUBJECTIVE: pt seen and examined.chart reviewed overnight events noted  no dyspnea hb 7.7 long discussion with Pharmacist will check PTT as pt bolused twice on heparin and Factor X a is not at goal.  pt currently on 31/min oxygen    if his hb trends down then we may need to stop all anticoagulation given risk of bleeding and patient is then agreeable to consider hospice on discharge  Comments:  THIS WRITER RECEIVED CPRS ALERT FROM FACILITY STAFF REGARDING PATIENT PASSING; VERIFIED INFORMATION.  FACILITY STAFF STATES PATIENT DOD 04/13/2023 TOD 0926 with HOME HEALTH AGENCY.  PATIENT, ON BEHALF OF THE FACILITY, REST IN PEACE.  Other Relevant HX:  Patient is a 79 y.o m, with history that includes, stage II ("Bulky") Mantle cell Lymphoma made by a celiac lymph node biopsy on 10/12/17. Last  chemotherapy of Rituximab on 12/12/22, here at facility.  The patient presented testerday to facility ED with 2 days history of fever   (Tmax 103), fatigue, vomiting,diarrhea,  decerase oral intake, generalized  body aches, dyspnea and dry cough.  Other:
Age: 55.0
Sex: M
Vaccine: FLU4, PNC20
Symptoms: Rash
Clinical narrative: Reported Symptoms:  10037844:RASH;    Narrative:  Other
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10042772:SYNCOPE;     Narrative:  Patient reported to ED on 11/26/22 with complaints of SOB and cough with phlegm and dx with COPD exacerbation as patient has had several admissions previously very similar to this.  Follows with pulmonary and was started on prednisone 60mg taper, but symptoms did not improve so patient came to ED. Upon admission had incidental COVID19 positive screening. Patient denied loss of smell, diarrhea, or generalized aches/pains.  It was not able to be determined if positive screening contributed to COPD exacerbation.   COPD exacerbation was treated with corticosteroids, bronchodilators, and mucolytic.  COVID was treated with symptomatic care.   Other Relevant HX:  PMH significant for CAD, GAD, severe COPD (not on home O2), pAFib, adrenal insufficiency d/2 chronic prednisone use.   Other:
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Productive cough, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10011232:COUGHING;  10042772:SYNCOPE;     Narrative:  Patient reported to ED on 11/26/22 with complaints of SOB and cough with phlegm and dx with COPD exacerbation as patient has had several admissions previously very similar to this.  Follows with pulmonary and was started on prednisone 60mg taper, but symptoms did not improve so patient came to ED. Upon admission had incidental COVID19 positive screening. Patient denied loss of smell, diarrhea, or generalized aches/pains.  It was not able to be determined if positive screening contributed to COPD exacerbation.   COPD exacerbation was treated with corticosteroids, bronchodilators, and mucolytic.  COVID was treated with symptomatic care.   Other Relevant HX:  PMH significant for CAD, GAD, severe COPD (not on home O2), pAFib, adrenal insufficiency d/2 chronic prednisone use.   Other:
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Malaise, Peripheral swelling
Clinical narrative: Reported Symptoms: 1015150:ERYTHEMA; 10016383:FELT ILL; 10042674:SWELLING; Narrative: Pt reported this historical reaction to flu shot so little information available for further details of reaction. Pt reported to Primary Care Provider had a reaction to flu shot of having a large area of redness and swelling to arm and being very ill. Other Relevant HX: Other: swelling, erythema, very "ill"
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Hypersensitivity, Mast cell activation syndrome, Pruritus, Rash
Clinical narrative: Reported Symptoms:  10037007:PRURITUS; 10037844:RASH;  10075217:MAST CELL ACTIVATION SYNDROME;  Narrative: The patient presented with urticaria, and sensitivity to foods and other vaccines after receiving the Jannsen Covid 19 vaccine on 16 Sep 2021 per primary care note on 28 Sep 2021, which is thought to be history of mast cell activation syndrome happening the first time after COVID-19 infection.  The patient was treated with famotidine and diphenhydramine.  Other Relevant HX:  Other:  Mast cell activation syndrome
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Reported Symptoms:  10037007:PRURITUS; 10037844:RASH;  10075217:MAST CELL ACTIVATION SYNDROME;  Narrative: The patient presented with urticaria, and sensitivity to foods and other vaccines after receiving the Jannsen Covid 19 vaccine on 16 Sep 2021 per primary care note on 28 Sep 2021, which is thought to be history of mast cell activation syndrome happening the first time after COVID-19 infection.  The patient was treated with famotidine and diphenhydramine.  Other Relevant HX:  Other:  Mast cell activation syndrome
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal tenderness, Acute respiratory failure, Blood lactic acid increased, Blood loss anaemia, COVID-19
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10019211:HEADACHE; 10043088:TACHYPNEA; Narrative: ASSESSMENT & PLAN: 82 y/o Male with Hx of Colon CA s/p partial colectomy, ileostomy, DVT/PE on anticoagulation who presents with dark and bloody stool x 3 days here for suspected GI bleed ACUTE: #GI bleed (suspect lower) #Acute blood loss anemia 2/2 above #COVID-19 positive, chronic - precautions cleared by ID #acute on chronic hypoxic respiratory failure #iatrogenic bleeding disorder 2/2 AC for chronic PE/DVT #Type II DM on insulin # hematuri Other Relevant HX: Patient is an 82 yo who presents to the ED FEB 23,2023@ 02:19:37 Subjective/Chief Complaint: Pt to ED with c/o onset fever, chills, cough, headache, and SOB ~ 2 hours ago. States just got back from traveling yesterday. ED Physician: diabetic, travelling, hypoxic now, covid +, PNA, UTI, mild ileus on CT Abd. Tachy, 2 l of fluid, Rocephin, lactic acid elevated. MRSA positive. Colon CA with colostomy mild abd tenderness. Other:
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills, Computerised tomogram abdomen abnormal, Cough, Dyspnoea, Faeces discoloured
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10019211:HEADACHE; 10043088:TACHYPNEA; Narrative: ASSESSMENT & PLAN: 82 y/o Male with Hx of Colon CA s/p partial colectomy, ileostomy, DVT/PE on anticoagulation who presents with dark and bloody stool x 3 days here for suspected GI bleed ACUTE: #GI bleed (suspect lower) #Acute blood loss anemia 2/2 above #COVID-19 positive, chronic - precautions cleared by ID #acute on chronic hypoxic respiratory failure #iatrogenic bleeding disorder 2/2 AC for chronic PE/DVT #Type II DM on insulin # hematuri Other Relevant HX: Patient is an 82 yo who presents to the ED FEB 23,2023@ 02:19:37 Subjective/Chief Complaint: Pt to ED with c/o onset fever, chills, cough, headache, and SOB ~ 2 hours ago. States just got back from traveling yesterday. ED Physician: diabetic, travelling, hypoxic now, covid +, PNA, UTI, mild ileus on CT Abd. Tachy, 2 l of fluid, Rocephin, lactic acid elevated. MRSA positive. Colon CA with colostomy mild abd tenderness. Other:
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haematochezia, Haematuria, Haemorrhagic disorder, Headache, Ileus
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10019211:HEADACHE; 10043088:TACHYPNEA; Narrative: ASSESSMENT & PLAN: 82 y/o Male with Hx of Colon CA s/p partial colectomy, ileostomy, DVT/PE on anticoagulation who presents with dark and bloody stool x 3 days here for suspected GI bleed ACUTE: #GI bleed (suspect lower) #Acute blood loss anemia 2/2 above #COVID-19 positive, chronic - precautions cleared by ID #acute on chronic hypoxic respiratory failure #iatrogenic bleeding disorder 2/2 AC for chronic PE/DVT #Type II DM on insulin # hematuri Other Relevant HX: Patient is an 82 yo who presents to the ED FEB 23,2023@ 02:19:37 Subjective/Chief Complaint: Pt to ED with c/o onset fever, chills, cough, headache, and SOB ~ 2 hours ago. States just got back from traveling yesterday. ED Physician: diabetic, travelling, hypoxic now, covid +, PNA, UTI, mild ileus on CT Abd. Tachy, 2 l of fluid, Rocephin, lactic acid elevated. MRSA positive. Colon CA with colostomy mild abd tenderness. Other:
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lower gastrointestinal haemorrhage, Pneumonia, Pyrexia, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10019211:HEADACHE; 10043088:TACHYPNEA; Narrative: ASSESSMENT & PLAN: 82 y/o Male with Hx of Colon CA s/p partial colectomy, ileostomy, DVT/PE on anticoagulation who presents with dark and bloody stool x 3 days here for suspected GI bleed ACUTE: #GI bleed (suspect lower) #Acute blood loss anemia 2/2 above #COVID-19 positive, chronic - precautions cleared by ID #acute on chronic hypoxic respiratory failure #iatrogenic bleeding disorder 2/2 AC for chronic PE/DVT #Type II DM on insulin # hematuri Other Relevant HX: Patient is an 82 yo who presents to the ED FEB 23,2023@ 02:19:37 Subjective/Chief Complaint: Pt to ED with c/o onset fever, chills, cough, headache, and SOB ~ 2 hours ago. States just got back from traveling yesterday. ED Physician: diabetic, travelling, hypoxic now, covid +, PNA, UTI, mild ileus on CT Abd. Tachy, 2 l of fluid, Rocephin, lactic acid elevated. MRSA positive. Colon CA with colostomy mild abd tenderness. Other:
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Staphylococcus test positive, Tachypnoea, Urinary tract infection
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10016558:FEVER; 10019211:HEADACHE; 10043088:TACHYPNEA; Narrative: ASSESSMENT & PLAN: 82 y/o Male with Hx of Colon CA s/p partial colectomy, ileostomy, DVT/PE on anticoagulation who presents with dark and bloody stool x 3 days here for suspected GI bleed ACUTE: #GI bleed (suspect lower) #Acute blood loss anemia 2/2 above #COVID-19 positive, chronic - precautions cleared by ID #acute on chronic hypoxic respiratory failure #iatrogenic bleeding disorder 2/2 AC for chronic PE/DVT #Type II DM on insulin # hematuri Other Relevant HX: Patient is an 82 yo who presents to the ED FEB 23,2023@ 02:19:37 Subjective/Chief Complaint: Pt to ED with c/o onset fever, chills, cough, headache, and SOB ~ 2 hours ago. States just got back from traveling yesterday. ED Physician: diabetic, travelling, hypoxic now, covid +, PNA, UTI, mild ileus on CT Abd. Tachy, 2 l of fluid, Rocephin, lactic acid elevated. MRSA positive. Colon CA with colostomy mild abd tenderness. Other:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cardiac failure congestive, Cardiomyopathy, Dyspnoea, Oedema
Clinical narrative: Reported Symptoms:  10007636:CARDIOMYOPATHY; 10010684:CONGESTIVE HEART FAILURE; 10014210:EDEMA; 10033556:PALPITATION; 10043888:TACHYPNEA;  Narrative: Patient presented to the hospital with shortness of breath, weakness, heart palpitations, and gasping throughout the night approximately two weeks after receiving the 2nd Moderna COVID 19 vaccine Feb 2021. The patient was referred to cardiology in which she was diagnosed with congestive heart failure.   The patient's symptoms are still ongoing and she is treated with furosemide.    Other Relevant HX;  Other; CHF, cardiomyopathy, edema
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Tachypnoea
Clinical narrative: Reported Symptoms:  10007636:CARDIOMYOPATHY; 10010684:CONGESTIVE HEART FAILURE; 10014210:EDEMA; 10033556:PALPITATION; 10043888:TACHYPNEA;  Narrative: Patient presented to the hospital with shortness of breath, weakness, heart palpitations, and gasping throughout the night approximately two weeks after receiving the 2nd Moderna COVID 19 vaccine Feb 2021. The patient was referred to cardiology in which she was diagnosed with congestive heart failure.   The patient's symptoms are still ongoing and she is treated with furosemide.    Other Relevant HX;  Other; CHF, cardiomyopathy, edema
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Cough, Intensive care, Respiratory distress
Clinical narrative: Reported Symptoms: 10011232:COUGHING; Narrative: Patient is a delightful 73 yo with a history of well-controlled moderate COPD on triple therapy who is incidentally found to be COVID-19 positive on pre-procedure nasal swab. He is currently with mild symptoms of coughing that is unchanged from chronic dry cough. He is requiring 1L above his home oxygen requirement with current oxygen saturations in the mid-90s. As patient is at high risk for COVID-19 Pneumonia leading to worsening respiratory status the MICU team has been consulted. #COVID-19 positive #Moderate COPD, GOLD 3A, not in exacerbation, #Acute on chronic Hypoxic respiratory failure 2/2 above on nocturnal oxygen (2L) #PAD s/p #T2DM #Pulm Nodules, followed by Pulm clinic #HTN PLAN: - Obtain CXR. - Initiate remdesivir, 3 days total of therapy in high risk patient with mild symptoms. - Use supplemental oxygen to keep O2 saturations >88% in COPD patient. - Continue bronchodilator therapy with duonebs and home inhalers. - Will continue to follow. Other Relevant HX: HPI: 73-year-old male with moderate COPD on triple therapy, ex smoker quit 2019 (45 pack years), with PMH of PAD, DM2, HTN, Hyperlipidemia who was admitted to the SICU post-surgical intervention for PAD and MICU team consulted for COVID-19 positive results. Patient surprised he is COVID-19 positive. Patient has dry cough that is unchanged from baseline. No sputum, no hemoptysis. No wheezing. No fevers or chills. No headache. No N/V/D. No nasal congestion or sore throat, no loss of taste or smell. No fatigue or loss of appetite. He is vaccinated for COVID-19 and received his boosters. #COVID-19 positive #Moderate COPD, GOLD 3A, not in exacerbation #Acute on chronic Hypoxic respiratory failure 2/2 above on nocturnal oxygen (2L) #PAD s/p #T2DM #Pulm Nodules, followed by Pulm clinic #HTN PLAN: - Obtain CXR. - Initiate remdesivir, 3 days total of therapy in high risk patient with mild symptoms. - Use supplemental oxygen to keep O2 saturations >88% in COPD patient. - Continue bronchodilator therapy with duonebs and home inhalers. - Will continue to follow. Other:
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Surgery
Clinical narrative: Reported Symptoms: 10011232:COUGHING; Narrative: Patient is a delightful 73 yo with a history of well-controlled moderate COPD on triple therapy who is incidentally found to be COVID-19 positive on pre-procedure nasal swab. He is currently with mild symptoms of coughing that is unchanged from chronic dry cough. He is requiring 1L above his home oxygen requirement with current oxygen saturations in the mid-90s. As patient is at high risk for COVID-19 Pneumonia leading to worsening respiratory status the MICU team has been consulted. #COVID-19 positive #Moderate COPD, GOLD 3A, not in exacerbation, #Acute on chronic Hypoxic respiratory failure 2/2 above on nocturnal oxygen (2L) #PAD s/p #T2DM #Pulm Nodules, followed by Pulm clinic #HTN PLAN: - Obtain CXR. - Initiate remdesivir, 3 days total of therapy in high risk patient with mild symptoms. - Use supplemental oxygen to keep O2 saturations >88% in COPD patient. - Continue bronchodilator therapy with duonebs and home inhalers. - Will continue to follow. Other Relevant HX: HPI: 73-year-old male with moderate COPD on triple therapy, ex smoker quit 2019 (45 pack years), with PMH of PAD, DM2, HTN, Hyperlipidemia who was admitted to the SICU post-surgical intervention for PAD and MICU team consulted for COVID-19 positive results. Patient surprised he is COVID-19 positive. Patient has dry cough that is unchanged from baseline. No sputum, no hemoptysis. No wheezing. No fevers or chills. No headache. No N/V/D. No nasal congestion or sore throat, no loss of taste or smell. No fatigue or loss of appetite. He is vaccinated for COVID-19 and received his boosters. #COVID-19 positive #Moderate COPD, GOLD 3A, not in exacerbation #Acute on chronic Hypoxic respiratory failure 2/2 above on nocturnal oxygen (2L) #PAD s/p #T2DM #Pulm Nodules, followed by Pulm clinic #HTN PLAN: - Obtain CXR. - Initiate remdesivir, 3 days total of therapy in high risk patient with mild symptoms. - Use supplemental oxygen to keep O2 saturations >88% in COPD patient. - Continue bronchodilator therapy with duonebs and home inhalers. - Will continue to follow. Other:
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hyperacusis, Photophobia
Clinical narrative: Reported Symptoms:  10019211:HEADACHE;  Narrative:  The patient presented to the ED on 26 April 2021, 23 May 2021, 12 Aug 22, and 1/27/23 with severe right sided headache after receiving the Moderna COVID 19 vaccine on 4/2/21. Headaches are localized on right side of the head and go to the neck.  Her headaches are worsened with light and noise.  When she has a headache, she must rest in bed in fetal position until headache resolves.  The patient was treated with NSAIDS and cyclobenzaprine.  Other Relevant HX:  Other: severe headache
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia
Clinical narrative: Reported Symptoms: 10028322:MUSCLE PAIN; Narrative: Other Relevant HX: Other: muscle pain
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cheilitis
Clinical narrative: Reported Symptoms: 10014625:ENCEPHALOPATHY; 10022221:INJURY TO KIDNEY; 10076918:HOSPITAL ACQUIRED PNEUMONIA; 10084268:COVID-19; Narrative: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other Relevant HX: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other: COVID, Hosp Acquired Pneumonia, AKI, Encephalopathy
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Clostridium difficile infection, Condition aggravated, Dehydration, Dementia
Clinical narrative: Reported Symptoms: 10014625:ENCEPHALOPATHY; 10022221:INJURY TO KIDNEY; 10076918:HOSPITAL ACQUIRED PNEUMONIA; 10084268:COVID-19; Narrative: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other Relevant HX: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other: COVID, Hosp Acquired Pneumonia, AKI, Encephalopathy
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Electrolyte imbalance, Encephalopathy, Hypertransaminasaemia, Hypophosphataemia
Clinical narrative: Reported Symptoms: 10014625:ENCEPHALOPATHY; 10022221:INJURY TO KIDNEY; 10076918:HOSPITAL ACQUIRED PNEUMONIA; 10084268:COVID-19; Narrative: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other Relevant HX: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other: COVID, Hosp Acquired Pneumonia, AKI, Encephalopathy
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic disorder, Pneumonia, Pneumonia bacterial, Rash vesicular, Renal impairment
Clinical narrative: Reported Symptoms: 10014625:ENCEPHALOPATHY; 10022221:INJURY TO KIDNEY; 10076918:HOSPITAL ACQUIRED PNEUMONIA; 10084268:COVID-19; Narrative: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other Relevant HX: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other: COVID, Hosp Acquired Pneumonia, AKI, Encephalopathy
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Renal injury, SARS-CoV-2 test positive, Superinfection
Clinical narrative: Reported Symptoms: 10014625:ENCEPHALOPATHY; 10022221:INJURY TO KIDNEY; 10076918:HOSPITAL ACQUIRED PNEUMONIA; 10084268:COVID-19; Narrative: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other Relevant HX: The patient recently was admitted to hospital 2 weeks before this admission and diagnosed with COVID-19 Pneumonia and AKI. He required oxygen but eventually was weaned off and tested COVID negative. He was then sent to a rehab facility. There he contracted C diff diarrhea and completed a course of oral antibiotics. However, due to his worsening renal function, he was transitioned to home with hospice care. While inpatient at the hospital he was tested positive for COVID-19 and was treated with dexamethasone and oxygen. Discharge diagnosis include: acute on chronic encephalopathy likely due to metabolic cause with dehydration, worsening Dementia declining care : Blood draws, IV Lines or any treatment, acute respiratory failure likely due to Covid syndrome and superimposed bacterial pneumonia: improved, transaminitis likely Covid related, nonspecific excoriating rash and blisters on the lips, acute kidney injury on chronic kidney disease stage IV, acute electrolyte disorder: Hypophosphatemia. Other: COVID, Hosp Acquired Pneumonia, AKI, Encephalopathy
Age: 93.0
Sex: F
Vaccine: FLUX
Symptoms: Anaemia, Cardiac failure congestive
Clinical narrative: 10/11/2023: Had an MI, Anemia, CHF, Admitted to Hospice.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Dysphagia, Hemiplegia, Ischaemic stroke
Clinical narrative: Stroke (ischemic), treated with tenectelplase w/in 3 hrs, outcome R sided paralysis dysphagia.
Age: 29.0
Sex: F
Vaccine: FLUA4, FLU4
Symptoms: Bursitis, Injection site pain, Pain
Clinical narrative: Subacromial bursitis; This spontaneous case was retrieved on 06-Dec-2023 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2709524-1) reported by other healthcare professional and concerned a 29-year-old, female patient.    The patient's relevant medical history and concomitant medications were not reported.  It was reported that on 27-Sep-2023, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: reported as '1', route of administration: intramuscular (IM), anatomical location: left arm (LA) and indication: not reported). The batch number reported was P100588968. The reported batch number was identified by Seqirus to be linked to the suspect product Afluria Quadrivalent (influenza vaccine inact sag 4v) instead of the reported suspect product Fluad Quadrivalent. Based on the reported batch number, the suspect product was changed to Afluria Quadrivalent.  On the same date, in the evening after receiving Afluria Quadrivalent, the patient began having pain.  On an unspecified date in 2023, (reported after approximately one month), the patient was seen for continued left shoulder pain and was diagnosed with subacromial bursitis.  At the time of the initial reporting, the patient had not recovered from the event.  The reporter did not provide a causality assessment.   The case was assessed as non-serious.  Company comment: A 29-year-old, female patient experienced pain on the same evening after being vaccinated with Afluria Quadrivalent. Approximately a month later, the patient visited physician due to shoulder pain that persisted since vaccination and was diagnosed with subacromial bursitis. Causality for reported event is assessed as possibly related, based on plausible temporal relationship.; Sender's Comments: A 29-year-old, female patient experienced pain on the same evening after being vaccinated with Afluria Quadrivalent. Approximately a month later, the patient visited physician due to shoulder pain that persisted since vaccination and was diagnosed with subacromial bursitis. Causality for reported event is assessed as possibly related, based on plausible temporal relationship.